• 中国科技论文统计源期刊
  • 中国科技核心期刊
  • 中国高校优秀期刊
  • 安徽省优秀科技期刊

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Bmi-1基因在肿瘤形成和发展中的研究进展

曹云飞 李德群

引用本文:
Citation:

Bmi-1基因在肿瘤形成和发展中的研究进展

    作者简介: 曹云飞(1975- ),男,硕士研究生,主治医师.
  • 基金项目:

  • 摘要: 多疏基因(ploycomb group genes,PcG)家族由多种与细胞周期和增殖相关的转录抑制子组成,是一类重要的与发育相关的基因。PcG参与对同源异型基因的表达抑制,并且与细胞增殖及肿瘤的发生密切相关。该家族成员包括B细胞特异莫洛尼白血病病毒插入位点1基因(Bmi-1基因)、
  • [2] van Lohuizen M,Verbeek S,Scheijen B,et al.Identification of cooperating on cogenes in E mu-myc transgenic mice by provirus yagging[J].Cell,1991,65(5):737-752.
    [2] van Lohuizen M,Frasch M,wientjens E,et al.Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and su(z)2[J].Nature,1991,353(6342):353-355.
    [3] Datta S,Hoenerhoff MJ,Bommi P,et al.Bmi-1 cooperates with HRas to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways[J].Cancer Res,2007,67(21):10286-10295.
    [4] Silva J,Garcia V,Garcia JM,et al.Circulating Bmi-1mRNA as a possible prognostic factor for advanced breast cancer patients[J].Breast Cancer Res,2007,9(4):R55.
    [5] Jacobs JJ,Kieboom K,Marino S,et al.The oneogene and polycomgroup gene bmi-1 regulates cell proliferation and senescence through the ink4a locus[J].Nature,1999,397(6715):164- 168.
    [6] van Kemenade FJ,Raaphorst FM,Blokzijl T,et al.Coexpression of BMI-1 and EZI-I 2 polycomb-group proteins is associated with cycling cells and degree of ma lignancy in B-cell non-Hodgkin lymphoma[J].Blood,2001,97(12):3896-3901.
    [7] hahana K,Zou Y,Itahana Y,et al.Contrel of the replicativel span of human f ibroblasts by p16 and the polycomb protein Bmi-1[J].Mol Cell Biol,2003,23(1):389-401.
    [8] Guo WJ,Zeng MS,Yadav A,et al.Mel-18 acts as a tumor suppresor by repressing Bmi-1 expression and down regulating Akt activin breast cancer cells[J].Cancer Res,2007,67(11):5083-5089.
    [9] Sherr CJ.The INK4a /ARF network in tumour suppression[J].Na tёv RMol Cell Biol,2001,2(10):731-737.
    [10] Braig M,Lee S,Loddenkemper C,et al.Oncogene-induced seneeenee as an initia-l barrier in lymphoma development[J].Nature,2005,436(7051):660-665.
    [11] Dimri GP,Martinez TL,Jacobs JJ,et al.The Bmi-1oncogene induces telomerase act ivity and immortalizes human mammary epithelial cells[J].Caner Res,2002,62(16):4736-4745.
    [12] Haga K,Ohno S,Yugawa T,et al.Efficient immortalization of primary human cells by p16INK4a-specific short hairpin RNA or Bmi-1,combined with introduction of hTERT[J].Cancer Sci,2007,98(2):147-154.
    [13] Kenney S,Ge JQ,Westphal EM,et al.Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas:comparison of two different Epstein-Barr virusbased vectors[J].Hum Gene Ther,1998,9(8):1131-1141.
    [14] Liu S,Dontu G,Mantle ID,et al.Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells[J].Cancer Res,2006,66(12):6063-6071.
    [15] Liu S,Dontu G,Wicha MS.Mammary stem cells,self-renewal pathways,and carcinogensis[J].Breast Cancer Res,2005,7(3):86-95.
    [16] Kim RH,Mehrazarin S,Oh JE,et al,Kang MK.Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF- signaling[J].Exp cell Ress,2010,316(16):2600-2608.
    [17] Meng S,Luo M,Sun H,et al.Identification and characterization of Bmi-1-responding element within the human p16 promoter[J].J Bio Chem,2010,285(43):33219-33229.
    [18] Park IK,Qian D,Kiel M,et al.Bmi-1 is required of or maintenance of adult self-renewing haematopoietic stem cells[J].Nature,2003,423(2):302-305.
    [19] Bruggeman A,Sophia WM,Valk-Lingbeek L,et al.Ink4a and Arf differentially affect cell proliferation and neural stem cell selfrenewal in Bmi-1 deficient mice [J].Genes Devel,2005,19(12):1438-1443.
    [20] Glinsky GV,Berezovska O,Glinskii AB.Microarray analysis idenifies a death from cancer signature predicting therapy failure in patients with multiple types of cancer[J].J Clin Invest,2005,115(6):1503-1521.
    [21] Dimri GP,Martinez JL,Jacobs JJ,et al.The Bmi-1 oncogene induces telomera se activity and immortalizes human mammary epithelial cells[J].Cancer Res,2002,62(16):4736-4745.
    [22] 冯艳,宋立兵,郭宝红,等.Bmi-1 在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157.
    [23] Li W,Li Y,Tan Y,et al.Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells[J].Gastroenterol Hepatol,2010,25(3):568-575.
    [24] Liu JH,Song LB,Zhang X,et al.Bmi-1 expression predicts prognosis for patients with gastric carcinoma[J].J Surg Oncol,2008,97(3):267-272.
    [25] Li DW,Tang HM,Fan JW,et al.Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer[J].J Cancer Ress Clin Oncol,2010,136(7):997-1006.
    [26] Lee MO,Lee HJ,Kin MA,et al.p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation[J].J Thorac Oncol,2011,6(3):423-431.
    [27] Zhang XY,Dong QG,Huang JS,et al.The expression of stem cellrelated indicators as a prognostic factor in human lung adenocarcinoma[J].J Surg Oncol,2010,102(7):856-862.
    [28] Vonlanthen S,Heighway J,Ahtermatt HJ.et al.The bmi-l oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression[J].B J Cancer,2001,84(10):1372-1376.
    [29] Jagani Z,Wiederschain D,Loo A,et al.The polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells[J].Cancer Res,2010,70(13):5528-5538.
    [30] Sawa M,Yamamoto K,Yokozawa T,et al.Bmi-1 is highly expressed in M0-subtype acut emyeloid leukemia [J].Int J Hematol,2005,82(1):42-47.
    [31] Mihara K,Chowdhury M,Nakaju N,et al.Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastie syndrome and patient prognosis[J].Blood,2006,107(1):305-308.
    [32] Zhang F,Sui L,Xin T.Correlations of Bmi-1 expression and telomerase activity in ovarian cancer tissues[J].Exp Oncol,2008,30(1):70-74.
    [33] Bhattacharya R,Kwon J,Ali B,et al.Role of hedgehog signaling in ovarian cancer [J].Clin Cancer Res,2008,14(23):7659-7666.
    [34] Godlewski J,Nowicki MO,Bronisz A,et al.Targeting of the Bmi-1 oneogene stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-ren ewa1[J].Cance Res,2008,68(22):9125-9130.
    [35] Kozakowski N,Soleiman A,Pammer J.Bmi-1 expression is inversely correlated with the grading of renal clear cell carcinoma[J].Pathol Oncol Res,2008,14(1):9-13.
    [36] Song LB,Zeng MS,Liao WT,et al.Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells[J].Cancer Res, 2006,66(12):6225-6232.
    [37] Balasubramanian S,Adhikary G,Eckert RL.The Bmi-1 polycomb protein antagonizes the(-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival[J].Carcinogenesis,2010,31(3):496-503.
  • [1] 张思铭陈汉杨柳刘梅 . SASH1基因在肿瘤研究中的进展. 蚌埠医学院学报, 2021, 46(5): 699-701. doi: 10.13898/j.cnki.issn.1000-2200.2021.05.035
    [2] 张发良闵大六 . CYP3A基因在肿瘤中的研究进展. 蚌埠医学院学报, 2011, 36(2): 201-204.
    [3] 郝海波许培权 . 抑癌基因p16与恶性肿瘤关系的研究进展. 蚌埠医学院学报, 2012, 36(3): 361-363.
    [4] 钱军 . 基因测序在肿瘤精准治疗中应用研究进展. 蚌埠医学院学报, 2018, 43(10): 1298-1300. doi: 10.13898/j.cnki.issn.1000-2200.2018.10.008
    [5] 杨洋郑荣生 . 细胞周期检查点激酶1在相关肿瘤中的研究现状. 蚌埠医学院学报, 2011, 36(2): 208-213.
    [6] 沈圆兵陈余清 . 乏氧诱导因子-1信号转导在肿瘤发生、发展中的作用. 蚌埠医学院学报, 2012, 36(2): 240-243.
    [7] 朱小康韩福生 . 缺氧诱导因子-1在恶性肿瘤发生、发展和治疗中的作用. 蚌埠医学院学报, 2010, 35(2): 211-214.
    [8] 刘浩 . 硫酸乙酰肝素蛋白聚糖的抗肿瘤作用. 蚌埠医学院学报, 2005, 30(2): 179-181.
    [9] 陈晓王启之 . 激活素、抑制素与肿瘤的研究进展. 蚌埠医学院学报, 2010, 35(5): 534-536.
    [10] 朱诺黄关宏王忠明 . 碳酸酐酶Ⅸ在肿瘤研究中的进展. 蚌埠医学院学报, 2011, 36(4): 432-434.
    [11] 杨卫富李德春 . Stat3与肿瘤的关系研究进展. 蚌埠医学院学报, 2013, 37(2): 234-236.
    [12] 张传海许戈良傅斌生 . 三氧化二砷抗肿瘤作用机制研究进展. 蚌埠医学院学报, 2006, 31(2): 219-221.
    [13] 杨芬蒋志文 . 内质网应激对肿瘤发展及化疗反应的影响. 蚌埠医学院学报, 2009, 34(5): 457-459.
    [14] 赵艳于东红 . 核不均一核糖核蛋白K在肿瘤研究中的概况. 蚌埠医学院学报, 2011, 36(5): 533-535.
    [15] 李才政李庆文 . EphA2及其与肿瘤关系的研究进展. 蚌埠医学院学报, 2011, 36(1): 107-109.
    [16] 程秀刘浩蒋志文 . 硫酸乙酰肝素对肿瘤中碱性成纤维因子的调控作用. 蚌埠医学院学报, 2012, 36(2): 237-240.
    [17] 李振刘建民 . 神经纤毛蛋白2在相关肿瘤中的研究现状. 蚌埠医学院学报, 2013, 37(5): 637-639.
    [18] 浦龙健刘浩蒋琛琛 . 肿瘤多药耐药机制及逆转策略的研究进展. 蚌埠医学院学报, 2014, 38(3): 409-412.
    [19] 邵俊峰陈余清 . 间充质干细胞与肿瘤关系的研究进展. 蚌埠医学院学报, 2019, 44(1): 134-137. doi: 10.13898/j.cnki.issn.1000-2200.2019.01.038
    [20] 雷思雨陈曼曼陈斌李玉云 . 细胞自噬与肿瘤微环境的关系研究进展. 蚌埠医学院学报, 2018, 43(7): 979-981. doi: 10.13898/j.cnki.issn.1000-2200.2018.07.043
  • 加载中
计量
  • 文章访问数:  3575
  • HTML全文浏览量:  466
  • PDF下载量:  108
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-03-02
  • 刊出日期:  2012-12-15

Bmi-1基因在肿瘤形成和发展中的研究进展

    作者简介: 曹云飞(1975- ),男,硕士研究生,主治医师.
  • 1. 蚌埠医学院第一附属医院肿瘤外科, 安徽蚌埠 233004
基金项目: 

摘要: 多疏基因(ploycomb group genes,PcG)家族由多种与细胞周期和增殖相关的转录抑制子组成,是一类重要的与发育相关的基因。PcG参与对同源异型基因的表达抑制,并且与细胞增殖及肿瘤的发生密切相关。该家族成员包括B细胞特异莫洛尼白血病病毒插入位点1基因(Bmi-1基因)、

参考文献 (37)

目录

    /

    返回文章
    返回